Aileron Therapeutics, Inc. (ALRN)
USD 1.86
(-3.13%)
USD 1.86
(-3.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -19.8 Million | -24.86 Million | -23.75 Million | -20.47 Million | -26.47 Million | -27.92 Million |
| Net Income | -15.73 Million | -27.32 Million | -26.16 Million | -21.15 Million | -29.36 Million | -31.54 Million |
| Depreciation & Amortization | 119 Thousand | 169 Thousand | 121 Thousand | 163 Thousand | 155 Thousand | 218 Thousand |
| Deferred income taxes | 4.98 Million | - | - | - | - | - |
| Stock-based compensation | 1.19 Million | 2.08 Million | 2.26 Million | 1.89 Million | 2.11 Million | 3.28 Million |
| Change in working capital | -5.38 Million | 420 Thousand | 242 Thousand | -1.28 Million | 850 Thousand | 376 Thousand |
| Other non-cash items | -4.98 Million | -208 Thousand | -213 Thousand | -95 Thousand | -226 Thousand | -253 Thousand |
| Investing Cash Flow | 16.19 Million | 26.45 Million | -35.91 Million | 6.41 Million | -2.81 Million | 24.68 Million |
| Investments in PPE | - | - | -157 Thousand | -5000.00 | -151 Thousand | -4.42 Million |
| Acquisitions | -54 Thousand | - | 66 Thousand | 208 Thousand | 2663.00 | - |
| Investment purchases | - | -21.85 Million | -73.57 Million | -10.03 Million | -27.23 Million | -31.19 Million |
| Sales/Maturities of investments | 16.25 Million | 48.3 Million | 37.75 Million | 16.24 Million | 24.57 Million | 60.3 Million |
| Other Investing Activities | 16.29 Thousand | 26.45 Thousand | -35.76 Thousand | 6416.00 | -2663.00 | 29.11 Million |
| Financing Cash Flow | 15.79 Million | - | 55.65 Million | 15.8 Million | 23.96 Million | 2.51 Million |
| Debt repayment | -15.79 Thousand | - | - | -387 Thousand | - | -2.47 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 55.65 Million | 15.41 Million | 23.79 Million | 42 Thousand |
| Other Financing Activities | 15.79 Million | - | 55.65 Million | 774 Thousand | 165 Thousand | 2.51 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -4.98 Million | 510 Thousand | -386 Thousand | 116 Thousand | -277 Thousand | 130 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -399 Thousand | -90 Thousand | 628 Thousand | -1.39 Million | 1.12 Million | 246 Thousand |
| Cash at beginning of period | 5.21 Million | 3.62 Million | 7.63 Million | 5.9 Million | 11.22 Million | 11.95 Million |
| Cash at end of period | 17.33 Million | 5.21 Million | 3.62 Million | 7.63 Million | 5.9 Million | 11.22 Million |
| Capital Expenditure | - | - | -157 Thousand | -5000.00 | -151 Thousand | -4.42 Million |
| Effect of forex changes on cash | -63 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | 12.11 Million | 1.59 Million | -4.01 Million | 1.73 Million | -5.32 Million | -723 Thousand |
| Free Cash Flow | -19.8 Million | -24.86 Million | -23.91 Million | -20.48 Million | -26.62 Million | -32.34 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.94 Million | -7.11 Million | -7.33 Million | -15.73 Million | -1.82 Million | -1.78 Million |
| Depreciation & Amortization | 4000.00 | 59 Thousand | 52 Thousand | 119 Thousand | 12 Thousand | 12 Thousand |
| Deferred income taxes | - | - | -4.12 Million | 4.98 Million | - | - |
| Stock-based compensation | 326 Thousand | 150 Thousand | 270 Thousand | 1.19 Million | 229 Thousand | 300 Thousand |
| Change in working capital | 223 Thousand | 1.63 Million | -3.55 Million | -5.38 Million | -11 Thousand | -1.58 Million |
| Other non-cash items | 1.7 Million | -698 Thousand | 4.29 Million | -4.98 Million | -43 Thousand | -52 Thousand |
| Investing Cash Flow | - | - | -96 Thousand | 16.19 Million | 542 Thousand | 8.5 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | -96 Thousand | -54 Thousand | 42 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 16.25 Million | 500 Thousand | 8.5 Million |
| Other Investing Activities | - | - | 42 Thousand | 16.29 Thousand | 542.00 | 8500.00 |
| Financing Cash Flow | 18.26 Million | - | 15.79 Million | 15.79 Million | -33 Thousand | - |
| Debt repayment | - | - | -33 Thousand | -15.79 Thousand | -33 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 18.26 Million | - | - | - | - | - |
| Other Financing Activities | 18.26 Million | - | 15.79 Million | 15.79 Million | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.37 Million | 966 Thousand | -3.74 Million | -4.98 Million | 348 Thousand | -322 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.59 Million | 667 Thousand | 194 Thousand | -399 Thousand | -359 Thousand | -1.26 Million |
| Cash at beginning of period | 12.06 Million | 17.33 Million | 12.09 Million | 5.21 Million | 13.19 Million | 7.8 Million |
| Cash at end of period | 21.94 Million | 12.06 Million | 17.33 Million | 17.33 Million | 12.09 Million | 13.19 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 1000.00 | - | -63 Thousand | -63 Thousand | 33 Thousand | - |
| Net cash flow / Change in cash | 9.87 Million | -5.27 Million | 5.24 Million | 12.11 Million | -1.09 Million | 5.38 Million |
| Free Cash Flow | -8.38 Million | -5.27 Million | -10.39 Million | -19.8 Million | -1.64 Million | -3.11 Million |
ASIANTNE
IIPR-PA
1217
HDELY
1730
WBBW